UTI vs APEI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

UTI

38.8
AI Score
VS
APEI Wins

APEI

51.8
AI Score

Investment Advisor Scores

UTI

39score
Recommendation
SELL

APEI

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric UTI APEI Winner
Revenue 661.15M 515.61M UTI
Net Income 15.54M 33.40M APEI
Net Margin 2.4% 6.5% APEI
Operating Income 19.27M 43.08M APEI
ROE 4.5% 10.7% APEI
ROA 1.7% 6.1% APEI
Total Assets 897.86M 548.47M UTI
Debt/Equity 0.46 0.28 APEI
Current Ratio 1.30 2.91 APEI
Free Cash Flow -63.50M 71.99M APEI

Relative Price Performance (Last 90 Days)

UTI 1M: +11.3% · 3M: -11.0% APEI 1M: -12.7% · 3M: -6.5%

Current Technical Phase

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 56.8 · Price: $23.00

APEI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.0 · Price: $42.28

Fundamentals Snapshot

Metric UTI APEI
Market Cap — —
Forward P/E 31.3 11.3
Trailing P/E 38.0 16.1
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.6% 0.6%
Operating Margin 0.0% 0.1%
EPS 0.61 2.50
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, APEI is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.